Document Detail


Effect of carvedilol on portal pressure estimated by hepatic vein Doppler ultrasound waveform and damping index in cirrhotic patients.
MedLine Citation:
PMID:  20810049     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess the effect of Carvedilol in reducing portal pressure estimated non-invasively by studying Doppler ultrasound waveforms (DUS) and hepatic vein Damping Index (DI).
STUDY DESIGN: Quasi-experimental study.
PLACE AND DURATION OF STUDY: Department of Medical ICU in collaboration with Department of Radiology, JPMC, over a period of 6 months (June 1st to 30th November, 2008).
METHODOLOGY: Of the enrolled 65 patients, 47 patients (33 males and 14 females) completed the study. The mean age was 47.4 years. Cirrhotic patients of Hepatitis B, C, D (delta), B and C combined, B and D combined with varying degrees of portal hypertension were included in the study. Cirrhotic patients with bronchial asthma, congestive heart failure, Insulin dependent Diabetes, portal vein thrombosis and hepatorenal syndrome were excluded from the study. The patients were examined by color flow Doppler of the right hepatic vein before and after administration of Carvedilol. Their waveforms and Damping Index (DI) were recorded and compared by Wilcoxon signed ranks test through SPSS version 12.0. Responders were described as those showing a positive change in wave forms or a decrese of 0.10 or more in DI.
RESULTS: Of the 47 patients, 30 (63%) showed a positive response and 10 (21%) showed no favorable response to Carvedilol, while 7 (14%) patients showed deterioration. The mean DI on DUS dropped from 0.62 to 0.41 in responders after treatment, while in the non-responders it ranged between 0.42 and 0.57.
CONCLUSION: Ultrasonography Carvedilol reduced portal pressure of cirrhotic patients, as measured indirectly by the damping index of hepatic waveform by Doppler.
Authors:
Qurban Hussain; Aly Haider Badruddin; M Azhar Chaudhry; Fayyaz Ahmad; Amanullah Abbasi
Related Documents :
16378879 - Management of cirrhotic ascites: physiological basis of diuretic action.
20374299 - Portal vein thrombosis in egyptian patients with liver cirrhosis: role of methylenetetr...
3047519 - The effect of glipizide on extraction of insulin by the human cirrhotic and noncirrhoti...
18350629 - Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients.
2521279 - Sufentanil pharmacokinetics in patients with cirrhosis.
15612659 - Intestinal microflora in patients with liver cirrhosis.
2396809 - Results of microvascular decompression of the eighth nerve as treatment for disabling p...
20739469 - Correlations between m-charts and php findings and subjective perception of metamorphop...
20009749 - Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papi...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP     Volume:  20     ISSN:  1022-386X     ISO Abbreviation:  J Coll Physicians Surg Pak     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-02     Completed Date:  2010-11-02     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  9606447     Medline TA:  J Coll Physicians Surg Pak     Country:  Pakistan    
Other Details:
Languages:  eng     Pagination:  586-9     Citation Subset:  IM    
Affiliation:
Medical ICU, Jinnah Postgraduate Medical Centre, Karachi. drqurbanhussain@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Adult
Aged
Blood Flow Velocity
Carbazoles / therapeutic use*
Female
Hepatic Veins / ultrasonography*
Humans
Hypertension, Portal / etiology,  physiopathology*,  ultrasonography
Liver Cirrhosis / complications,  physiopathology*,  ultrasonography
Male
Middle Aged
Portal Pressure / drug effects*
Propanolamines / therapeutic use*
Ultrasonography, Doppler, Color
Ultrasonography, Doppler, Duplex*
Young Adult
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 0K47UL67F2/carvedilol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment profile of hepatitis C patients - a comparison of interferon alpha 2a and 2b treatment reg...
Next Document:  Age related association of her-2/neu with prognostic markers in female breast carcinoma.